BTA 0.00% 57.0¢ biota holdings limited

h3n2v flu strains emerging in usa, page-7

  1. 9,580 Posts.
    lightbulb Created with Sketch. 310
    It looks like BioCryst is filling the NDA for Peramivir... beating us by the mile run... The good thing is the drug is for intravenous...

    RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--

    BioCryst Pharmaceuticals, Inc. (BCRX) today announced that the Biomedical Advanced Research and Development Authority (BARDA/HHS) has released funding under the current $234.8 million contract to enable completion of a New Drug Application (NDA) filing for intravenous (i.v.) peramivir. BioCryst is seeking an indication for the treatment of acute uncomplicated influenza and expects to submit the peramivir NDA by the end of 2013.



    http://finance.yahoo.com/news/biocryst-file-peramivir-nda-supported-130100385.html
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.